Literature DB >> 16699003

The cytoplasmic tail of the influenza A virus M2 protein plays a role in viral assembly.

Kiyoko Iwatsuki-Horimoto1, Taisuke Horimoto, Takeshi Noda, Maki Kiso, Junko Maeda, Shinji Watanabe, Yukiko Muramoto, Ken Fujii, Yoshihiro Kawaoka.   

Abstract

The viral replication cycle concludes with the assembly of viral components to form progeny virions. For influenza A viruses, the matrix M1 protein and two membrane integral glycoproteins, hemagglutinin and neuraminidase, function cooperatively in this process. Here, we asked whether another membrane protein, the M2 protein, plays a role in virus assembly. The M2 protein, comprising 97 amino acids, possesses the longest cytoplasmic tail (54 residues) of the three transmembrane proteins of influenza A viruses. We therefore generated a series of deletion mutants of the M2 cytoplasmic tail by reverse genetics. We found that mutants in which more than 22 amino acids were deleted from the carboxyl terminus of the M2 tail were viable but grew less efficiently than did the wild-type virus. An analysis of the virions suggested that viruses with M2 tail deletions of more than 22 carboxy-terminal residues apparently contained less viral ribonucleoprotein complex than did the wild-type virus. These M2 tail mutants also differ from the wild-type virus in their morphology: while the wild-type virus is spherical, some of the mutants were filamentous. Alanine-scanning experiments further indicated that amino acids at positions 74 to 79 of the M2 tail play a role in virion morphogenesis and affect viral infectivity. We conclude that the M2 cytoplasmic domain of influenza A viruses plays an important role in viral assembly and morphogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16699003      PMCID: PMC1472145          DOI: 10.1128/JVI.00049-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Efficient selection for high-expression transfectants with a novel eukaryotic vector.

Authors:  H Niwa; K Yamamura; J Miyazaki
Journal:  Gene       Date:  1991-12-15       Impact factor: 3.688

2.  Growth restriction of influenza A virus by M2 protein antibody is genetically linked to the M1 protein.

Authors:  S L Zebedee; R A Lamb
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

3.  Genetic applications of an inverse polymerase chain reaction.

Authors:  H Ochman; A S Gerber; D L Hartl
Journal:  Genetics       Date:  1988-11       Impact factor: 4.562

4.  Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system.

Authors:  R B DuBridge; P Tang; H C Hsia; P M Leong; J H Miller; M P Calos
Journal:  Mol Cell Biol       Date:  1987-01       Impact factor: 4.272

5.  Influenza virus hemagglutinin concentrates in lipid raft microdomains for efficient viral fusion.

Authors:  Makoto Takeda; George P Leser; Charles J Russell; Robert A Lamb
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-15       Impact factor: 11.205

6.  Role of the M2 protein in influenza virus membrane fusion: effects of amantadine and monensin on fusion kinetics.

Authors:  R Bron; A P Kendal; H D Klenk; J Wilschut
Journal:  Virology       Date:  1993-08       Impact factor: 3.616

7.  Influenza B virus requires BM2 protein for replication.

Authors:  Masato Hatta; Hideo Goto; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

8.  Influenza B virus BM2 protein is a crucial component for incorporation of viral ribonucleoprotein complex into virions during virus assembly.

Authors:  Masaki Imai; Shinji Watanabe; Ai Ninomiya; Masatsugu Obuchi; Takato Odagiri
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

9.  Influenza virus M2 protein has ion channel activity.

Authors:  L H Pinto; L J Holsinger; R A Lamb
Journal:  Cell       Date:  1992-05-01       Impact factor: 41.582

10.  Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions.

Authors:  S L Zebedee; R A Lamb
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

View more
  87 in total

1.  An M2 cytoplasmic tail mutant as a live attenuated influenza vaccine against pandemic (H1N1) 2009 influenza virus.

Authors:  Yasuko Hatta; Masato Hatta; Pamuk Bilsel; Gabriele Neumann; Yoshihiro Kawaoka
Journal:  Vaccine       Date:  2011-01-25       Impact factor: 3.641

Review 2.  Novel vaccines against influenza viruses.

Authors:  S M Kang; J M Song; R W Compans
Journal:  Virus Res       Date:  2011-10-01       Impact factor: 3.303

Review 3.  Influenza A viruses: why focusing on M2e-based universal vaccines.

Authors:  Seyyed Mahmoud Ebrahimi; Majid Tebianian
Journal:  Virus Genes       Date:  2010-11-17       Impact factor: 2.332

4.  Role of the CM2 protein in the influenza C virus replication cycle.

Authors:  Takatoshi Furukawa; Yasushi Muraki; Takeshi Noda; Emi Takashita; Ri Sho; Kanetsu Sugawara; Yoko Matsuzaki; Yoshitaka Shimotai; Seiji Hongo
Journal:  J Virol       Date:  2010-11-24       Impact factor: 5.103

5.  Conformational analysis of the full-length M2 protein of the influenza A virus using solid-state NMR.

Authors:  Shu Yu Liao; Keith J Fritzsching; Mei Hong
Journal:  Protein Sci       Date:  2013-10-07       Impact factor: 6.725

6.  Structure-based design of NS2 mutants for attenuated influenza A virus vaccines.

Authors:  Hatice Akarsu; Kiyoko Iwatsuki-Horimoto; Takeshi Noda; Eiryo Kawakami; Hiroaki Katsura; Florence Baudin; Taisuke Horimoto; Yoshihiro Kawaoka
Journal:  Virus Res       Date:  2010-10-21       Impact factor: 3.303

7.  Cytoplasmic domain of influenza B virus BM2 protein plays critical roles in production of infectious virus.

Authors:  Masaki Imai; Kazunori Kawasaki; Takato Odagiri
Journal:  J Virol       Date:  2007-11-07       Impact factor: 5.103

8.  Extending the cytoplasmic tail of the influenza a virus M2 protein leads to reduced virus replication in vivo but not in vitro.

Authors:  Wai-Hong Wu; Andrew Pekosz
Journal:  J Virol       Date:  2007-11-07       Impact factor: 5.103

9.  Influenza virus hemagglutinin and neuraminidase, but not the matrix protein, are required for assembly and budding of plasmid-derived virus-like particles.

Authors:  Benjamin J Chen; George P Leser; Eiji Morita; Robert A Lamb
Journal:  J Virol       Date:  2007-05-02       Impact factor: 5.103

10.  Free-energy profiles for ions in the influenza M2-TMD channel.

Authors:  Morad Mustafa; Douglas J Henderson; David D Busath
Journal:  Proteins       Date:  2009-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.